Corey Davis
Stock Analyst at HC Wainwright & Co.
(2.91)
# 1,468
Out of 4,789 analysts
18
Total ratings
77.78%
Success rate
17.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corey Davis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Reiterates: Neutral | $32 → $26 | $0.68 | +3,723.53% | 5 | May 12, 2020 | |
| SCYX SCYNEXIS | Assumes: Buy | $50 | $0.95 | +5,151.55% | 3 | May 7, 2018 | |
| VTVT vTv Therapeutics | Downgrades: Neutral | $560 → $40 | $17.32 | +130.95% | 2 | Apr 10, 2018 | |
| LPCN Lipocine | Initiates: Buy | $170 | $3.18 | +5,245.91% | 1 | Mar 29, 2018 | |
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $20 | $4.59 | +335.73% | 2 | Jan 19, 2018 | |
| PCRX Pacira BioSciences | Initiates: Buy | $50 | $24.85 | +101.21% | 3 | Jan 19, 2018 | |
| CARA Cara Therapeutics | Initiates: Buy | $324 | $5.07 | +6,290.53% | 1 | Jan 19, 2018 | |
| JAZZ Jazz Pharmaceuticals | Initiates: Neutral | $144 | $124.15 | +15.99% | 1 | Aug 25, 2017 |
Nektar Therapeutics
May 12, 2020
Reiterates: Neutral
Price Target: $32 → $26
Current: $0.68
Upside: +3,723.53%
SCYNEXIS
May 7, 2018
Assumes: Buy
Price Target: $50
Current: $0.95
Upside: +5,151.55%
vTv Therapeutics
Apr 10, 2018
Downgrades: Neutral
Price Target: $560 → $40
Current: $17.32
Upside: +130.95%
Lipocine
Mar 29, 2018
Initiates: Buy
Price Target: $170
Current: $3.18
Upside: +5,245.91%
Vanda Pharmaceuticals
Jan 19, 2018
Initiates: Buy
Price Target: $20
Current: $4.59
Upside: +335.73%
Pacira BioSciences
Jan 19, 2018
Initiates: Buy
Price Target: $50
Current: $24.85
Upside: +101.21%
Cara Therapeutics
Jan 19, 2018
Initiates: Buy
Price Target: $324
Current: $5.07
Upside: +6,290.53%
Jazz Pharmaceuticals
Aug 25, 2017
Initiates: Neutral
Price Target: $144
Current: $124.15
Upside: +15.99%